Table 3.
Characteristics | Fontan (n=21) | Controls (n=21) | P-value§ |
---|---|---|---|
Plasma insulin, μU/mL | 6.9 (3–13.4) | 4.6 (1.9–6.3) | 0.05 |
High-sensitivity CRP, mg/L | 0.7 (0.3–1.0) | 0.3 (0.2–0.4) | 0.01 |
TNF-α, highly sensitive, pg/mL | 1.9 (1.7–2.4) | 2.2 (1.7–2.8) | 0.30 |
Hematocrit, % | 44.1 ± 2.5 | 36.3 ± 4.0 | <.0001 |
Platelet count, K/μL | 189 ± 80.3 | 245 ± 47.5 | 0.01 |
Fasting glucose | 81.1 ±6.2 | 90.2 ± 10.5 | 0.002 |
HOMA-IR | 1.3 (0.6–2.6) | 1.1 (0.4–1.5) | 0.15 |
Albumin, g/dL | 4.6 ± 0.3 | 4.0 ± 0.3 | <.0001 |
AST, IU/L | 31.8 ± 6.3 | 23.9 ± 5.7 | 0.0001 |
ALT, IU/L | 29.8 ± 8.1 | 17.5 ± 6.4 | <.0001 |
Total bilirubin, mg/dL | 0.99 ± 0.41 | 0.49 ± 0.23 | <.0001 |
GGTP, IU/L | 54.2 ± 24.3 | 10.8 ± 7.0 | <.0001 |
Data are presented as N (%) for categorical variables and Median (IQR) or Mean ± SD for continuous variables.
P-value from Wilcoxon rank sum test or t-test, as appropriate, on comparison of each laboratory value between Fontan patients and healthy controls.